PCSK9

All (3) PCSK9 Inhibitors (2) PCSK9 Antagonists (1)

Catalog No.	Information	Product Use Citations
S8420	R-IMPP R-IMPP is an inhibitor of PCSK9 secretion, half maximal inhibitory concentration [IC50] = 4.8 μM.
S0118	SBC-110736 SBC-110736 is an inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9) that lowers cholesterol levels in mice.
S7976	SBC-115076 SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.	Menopause, 2020, 27(10):1155-1166 Molecules, 2018, 23(9) J Virol, 2017, 91(16)e00461-17

Catalog No.

Information

Product Use Citations

Product Validations

S8420

R-IMPP is an inhibitor of PCSK9 secretion, half maximal inhibitory concentration [IC50] = 4.8 μM.

S0118

SBC-110736 is an inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9) that lowers cholesterol levels in mice.

S7976

SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.

Catalog No.	Information	Product Use Citations	Product Validations
S8420	R-IMPP R-IMPP is an inhibitor of PCSK9 secretion, half maximal inhibitory concentration [IC50] = 4.8 μM.
S0118	SBC-110736 SBC-110736 is an inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9) that lowers cholesterol levels in mice.

Catalog No.

Information

Product Use Citations

Product Validations

S8420

R-IMPP is an inhibitor of PCSK9 secretion, half maximal inhibitory concentration [IC50] = 4.8 μM.

S0118

SBC-110736 is an inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9) that lowers cholesterol levels in mice.

Catalog No.	Information	Product Use Citations	Product Validations
S7976	SBC-115076 SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.	Menopause, 2020, 27(10):1155-1166 Molecules, 2018, 23(9) J Virol, 2017, 91(16)e00461-17

Catalog No.

Information

Product Use Citations

Product Validations

S7976